A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
for Primary Photoreceptor Disease
Sites in Miami +4 more locations
Sponsor: BlueRock Therapeutics
Sex: All·Age: 18+
Code: NCT06789445·Phase 1, Phase 2·Recruiting·Listed Jan 2025